Atai Life Sciences N.V is a biopharmaceutical company which focuses on the treatment of mental health disorders. The company develops therapies that are safe, effective, and accessible to patients around the world, and aims to address unmet medical needs and improve patient outcomes. Atai also invests in and partners with other organisations that are working towards advanced mental health research and treatment.
You can trade Atai Life Sciences N.V under the healthcare sector. Last fiscal year, the company reached a revenue of $233,000 with an annual growth rate of -98.86%.
Learn more about the performance of ATAI stock on eToro.